FDA Approved: * February 8, 2019 Pharm Company: *TARO PHARM INDS LTD Category:Iron Chelator
Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union and in Asia for many years while awaiting approval in Canada and in the United States. On October 14, 2011, it was approved for use in the US under ...
* May have multiple approval dates, manufacturers, or labelers.